Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allison

Showing results (211-220 of 647) with videos related to

Pageof 65
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanismJohn J Engelhardt, Timothy J Sullivan, James P Allison
Immunological Reviews|September 2, 2008
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapyKarl S Peggs, Sergio A Quezada, James P Allison
Clinical and Experimental Immunology|August 8, 2009
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonistsK S Peggs, S A Quezada, J P Allison
Biochemical and Biophysical Research Communications|July 12, 1979
Sites including those of origin and termination of replication are not freely available to single-cut restriction endonucleases in the supercompact form of simian virus 40 minichromosomeG C Das, D P Allison, S K Niyogi
Current Opinion in Immunology|February 2, 2010
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)Tyler R Simpson, Sergio A Quezada, James P Allison
Journal of Molecular Biology|April 25, 1973
Intracellular events during infection by Haemophilus influenzae phage and transfection by its DNAN K Notani, J K Setlow, D P Allison
Cancer Immunity|August 17, 2012
Monoclonal antibodies in cancer therapyAndrew M Scott, James P Allison, Jedd D Wolchok
Journal of Virology|April 1, 1973
Bacteriophage of Haemophilus influenzae. 3. Morphology, DNA homology, and immunity properties of HPlcl, S2, and the defective bacteriophage from strain RdM E Boling, D P Allison, J K Setlow
Plos Biology|September 22, 2010
Attenuated T cell responses to a high-potency ligand in vivoEmily Corse, Rachel A Gottschalk, Michelle Krogsgaard, et al.
The Journal of Experimental Medicine|May 11, 2021
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapyNaveen Sharma, Oluwatomisin T Atolagbe, Zhongqi Ge, et al.
Pageof 65

Showing results (211-220 of 647) with videos related to

Sort By:
Pageof 65
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanismJohn J Engelhardt, Timothy J Sullivan, James P Allison
Immunological Reviews|September 2, 2008
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapyKarl S Peggs, Sergio A Quezada, James P Allison
Clinical and Experimental Immunology|August 8, 2009
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonistsK S Peggs, S A Quezada, J P Allison
Biochemical and Biophysical Research Communications|July 12, 1979
Sites including those of origin and termination of replication are not freely available to single-cut restriction endonucleases in the supercompact form of simian virus 40 minichromosomeG C Das, D P Allison, S K Niyogi
Current Opinion in Immunology|February 2, 2010
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)Tyler R Simpson, Sergio A Quezada, James P Allison
Journal of Molecular Biology|April 25, 1973
Intracellular events during infection by Haemophilus influenzae phage and transfection by its DNAN K Notani, J K Setlow, D P Allison
Cancer Immunity|August 17, 2012
Monoclonal antibodies in cancer therapyAndrew M Scott, James P Allison, Jedd D Wolchok
Journal of Virology|April 1, 1973
Bacteriophage of Haemophilus influenzae. 3. Morphology, DNA homology, and immunity properties of HPlcl, S2, and the defective bacteriophage from strain RdM E Boling, D P Allison, J K Setlow
Plos Biology|September 22, 2010
Attenuated T cell responses to a high-potency ligand in vivoEmily Corse, Rachel A Gottschalk, Michelle Krogsgaard, et al.
The Journal of Experimental Medicine|May 11, 2021
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapyNaveen Sharma, Oluwatomisin T Atolagbe, Zhongqi Ge, et al.
Pageof 65